Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Dusseldorf - Delayed Quote • EUR Terns Pharmaceuticals Inc (430.DU) Follow Add holdings 2.4800 -0.1000 (-3.88%) As of 9:10:12 AM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 430.DU 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 430.DU View More All News Press Releases SEC Filings We're Not Very Worried About Terns Pharmaceuticals' (NASDAQ:TERN) Cash Burn Rate Down -39.83% in 4 Weeks, Here's Why Terns Pharmaceuticals (TERN) Looks Ripe for a Turnaround Down -31.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Terns Pharmaceuticals (TERN) Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4) All You Need to Know About Terns Pharmaceuticals (TERN) Rating Upgrade to Buy Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates This Weight Loss Stock Could Skyrocket by 462%, According to Wall Street Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4) Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference Its CEO died. The company scrapped a promising program. Now, for their 2nd act. Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer Related Tickers 1VT.MU Viking Therapeutics Inc 22.46 +0.42% BCYC Bicycle Therapeutics plc 8.67 -0.69% JSPR Jasper Therapeutics, Inc. 4.5600 +4.35% MTSR Metsera, Inc. 23.58 +8.76% GPCR Structure Therapeutics Inc. 23.32 +1.22%